Earum Pharmaceuticals Ltd - 542724 - 11Thannual General Meeting Of The Company On Saturday, 16Th September, 2023 At 12:00 P.M. Through Video Conferencing To Transact The Businesses.
As per Attachment14-08-2023
Earum Pharmaceuticals Ltd - 542724 - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
Intimation under Regulation 30 of SEBI (LODR) Regulations,201514-08-2023
Earum Pharmaceuticals Ltd - 542724 - Announcement under Regulation 30 (LODR)-Change in Directorate
Intimation under Regulation 30 of SEBI (LODR) Regulations,201514-08-2023
Earum Pharmaceuticals Ltd - 542724 - Submission Of Unaudited Financial Results For The Quarter Ended On 30Th June, 2023 Along With Limited Review Report
Submission of Unaudited Financial Results for the Quarter ended on 30th, June 2023 along with Limited Review Report14-08-2023
Earum Pharmaceuticals Ltd - 542724 - Intimation Pertaining To Requests Received For Reclassification Of Shareholding From 'Promoter And Promoter Group' Category To 'Public' Category As Per Regulation 31A Of SEBI (LODR) Regulations, 2015
Intimation pertaining to requests received for Reclassification of Shareholding from "Promoter and Promoter Group" Category to "Public" Category as per Regulation 31A of SEBI(LODR) Regulation,2015.11-08-2023
Earum Pharmaceuticals Ltd - 542724 - Announcement under Regulation 30 (LODR)-Change in Registered Office Address
Intimation for change in Registered office of the Company i.e. within the City09-08-2023
Earum Pharmaceuticals Ltd - 542724 - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)
Intimation of Resignation of Chief Financial Officer09-08-2023
Earum Pharmaceuticals Ltd - 542724 - Announcement under Regulation 30 (LODR)-Resignation of Director
Intimation of Resignation of Director08-08-2023
Earum Pharmaceuticals Ltd - 542724 - Announcement under Regulation 30 (LODR)-Change in Directorate
Intimation of Appointment of Additional Director of the company.08-08-2023